586
Views
77
CrossRef citations to date
0
Altmetric
Liver and Biliary Tract

Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis

, , , PhD, , , , , & show all
Pages 619-625 | Received 10 Nov 2008, Published online: 08 Jul 2009

References

  • Kiyici M, Nak SG, Budak F, Gurel S, Oral B, Dolar E, et al. Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection. J Gastroenterol Hepatol 2006; 21: 963–9
  • Souza MH, Cunha FQ, Martinelli AL. Interleukin 6 concentration in ascitic fluid of cirrhotic patients: relationship with previous episodes of spontaneous bacterial peritonitis. J Gastroenterol 2003; 38: 149–52
  • Byl B, Roucloux I, Crusiaux A, Dupont E, Devière J. Tumor necrosis factor α and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 1993; 104: 1492–7
  • Harden LM, du Plessis I, Poole S, Laburn HP. Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiol Behav 2006; 89: 146–55
  • Wong, F, Bernardi, M, Balk, R, Christman, B, Moreau, R, Garcia-Tsao, G,. and the International Ascites Club, et al. Sepsis in cirrhosis: Report on the 7th Meeting of the International Ascites Club. Gut. 2005;54:718–25.
  • Ksontini R, MacKay SL, Moldawer LL. Revisiting the role of tumor necrosis factor α and the response to surgical injury and inflammation. Arch Surg 1998; 133: 558–67
  • Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J, et al. Tumor necrosis factor α, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 2001; 46: 2360–6
  • Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000; 97: 8841–8
  • Sakaguchi S, Furusawa S. Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol Med Microbiol 2006; 47: 167–77
  • Sansoè G, Silvano S, Mengozzi G, Smedile A, Todros L, Baronio M, et al. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal. Am J Gastroenterol 2002; 97: 2383–90
  • Blendis L, Wong F. Excess nitric oxide in pre-ascites: another piece in the puzzle. Am J Gastroenterol 2002; 97: 2167–9
  • Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403–9
  • Fernández J, Monteagudo J, Bargallo X, Jiménez W, Bosch J, Arroyo V, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 2005; 42: 627–34
  • Fernández J, Navasa M, Garcia-Pagan JC, G-Abraldes J, Jiménez W, Bosch J, et al. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol 2004; 41: 384–90
  • Brand RE. Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis: Is it worth the cost?. Am J Gastroenterol. 1999; 94: 3404
  • Runyon BA. Albumin infusion for spontaneous bacterial peritonitis. Lancet 1999; 354: 1838–9
  • Ghasemi A, Hedayati M, Biabani H. Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay. JMSR 2007; 15: 29–35
  • Navasa M, Follo A, Filella X, Planas R, Forns X, Francitorra A, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998; 27: 1227–32
  • Follo A, Llovet JM, Navasa M, Jiménez W, Francitorra A, Planas R, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994; 20: 1495–501
  • Ginès, P, Guevara, M, De Las Heras, D, Arroyo, V. Review article: albumin for circulatory support in patients with cirrhosis. Aliment Pharmacol Ther 2002;16(Suppl 5):24–31.
  • Zeni F, Tardy B, Vindimian M, Comtet C, Page Y, Cusey I, et al. High levels of tumor necrosis factor-α and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 1993; 17: 218–23
  • Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 1986; 232: 977–80
  • Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, et al. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 1999; 94: 169–77
  • Ruiter DJ, van der Meulen J, Brouwer A, Hummel MJ, Mauw BJ, van der Ploeg JC, et al. Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest 1981; 45: 38–45
  • Ghosh S, Latimer RD, Gray BM, Harwood RJ, Oduro A. Endotoxin-induced organ injury. Crit Care Med 1993; 21: S19–24
  • Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995; 22: 165–72
  • Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18: 1139–43
  • Battista S, Bar F, Mengozzi G, Zanon E, Grosso M, Molino G. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol 1997; 26: 75–80
  • Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–42
  • Bories PH, Campillo B, Azaou L, Scherman E. Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1997; 25: 1328–33
  • Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J, et al. Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 2004; 16: 571–7
  • Evans TW. Albumin as a drug: biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther 2002; 16: 6–11
  • Finkel M, Oddis C, Jacob T, Watkins S, Hattler B, Simmons R. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387–9
  • Awad SS, Sawada S, Soldes OS, Rich PB, Klein R, Alarcon WH, et al. Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system?. ASAIO J 1999; 45: 47–9
  • Rafikova O, Rafikov R, Nudler E. Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular control. Proc Natl Acad Sci 2002; 99: 5913–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.